Doctor Rena Hirani

Rena's work involves analysing molecular changes in patients who receive a blood transfusion, such as microchimerism.

She also analyses how blood components are used in hospitals with the aim of providing a better understanding of blood component usage and safety and improving outcomes for transfusion patients.  More recently she has worked in a large collaborative team to provide data to Australian Governments on the spread of COVID19 and other diseases which impact the Australian community.

Rena received her PhD in biochemistry and molecular biology from the University of Adelaide. Before joining Lifeblood, she worked as a Postdoctoral Fellow designing DNA nanomachines for point-of-care diagnosis and in developmental biology.